Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV
Related Posts
Kinzie PR, Lombe B, Merritt S, Halbrook M, Vakaniaki EH, Mukadi P, L'k'ye AM, Mona J, Kanonge D, Mfwangkang M, Witte D, Melofchik C, Muyembe-Tamfum[...]
Ramaswami R, Nordwall JA, Gilbert D, Kitchell E, Timiryasova A, Mitsuyasu R, Phillips AN, Lundgren J, Grabar S. Early antiretroviral therapy and long-term cancer risk[...]
Nasuuna EM, Hoffman R, Kalyesubula R, Chikwari CD, Weiss HA. Kidney abnormalities in young people living with HIV on dolutegravir-based regimens in Kampala, Uganda. AIDS[...]